Short interest in Fate Therapeutics Inc (NASDAQ:FATE) decreased during the last reporting period, falling from 16.06M to 15.90M. This put 16.03% of the company's publicly available shares short.

Short interest for Fate Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Fate Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.30M shares traded per day, it would take 12.26 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.